<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

CU Cancer Center News and Stories

Adavosertib

Cancer    Adavosertib

Adavosertib speeds cancer cells into the wall of mitotic catastrophe

A cancer cell is like a racecar, speeding through the process of cellular replication. But it has to stop at the G2M cell cycle checkpoint, where a race inspector called Wee1 checks it over for damage – cells with intact DNA can continue, while cells with damaged DNA have to stick around for repairs. The wait is worth it – there are curves ahead, and beyond the G2M checkpoint, cells with damaged DNA explode against the wall of “mitotic catastrophe.” But the thing is, we want cancer cells to explode; we would rather they speed through the G2M checkpoint without a Wee1 inspection and hit the wall of mitotic catastrophe.


Author Cancer Center | Publish Date April 01, 2019
Full Story

CU Cancer Center In the News

Biospace

ODAC Votes Against Safety Profile of Secura Bio’s P13K Inhibitor

news outletBiospace
Publish DateSeptember 26, 2022

In an 8-4 vote, the FDA’s Oncologic Drugs Advisory Committee Roster voted against the benefit-risk profile of Secura Bio’s P13K inhibitor Copiktra.

Full Story
Cancer Health

Abortion Ban Will Harm Women Diagnosed with Breast Cancer During Pregnancy

news outletCancer Health
Publish DateSeptember 22, 2022

Two CU Cancer Center members detail how the Supreme Court decision in Dobbs V. Jackson Women’s Health Organization will harm some patients.

Full Story
ET Healthworld

Researchers Discover New Imaging Information System May Provide Accurate Prognosis for Certain Cancers

news outletET Healthworld
Publish DateSeptember 20, 2022

A novel imaging information system developed by researchers at CU Anschutz may eventually provide a faster, more accurate prognosis for certain tumors.

Full Story
Cancer Health

Researchers Find Less Risky Way to Monitor Breast Cancer Progression

news outletCancer Health
Publish DateSeptember 20, 2022

CU Cancer Center researchers have discovered how to extract critical information about breast cancer tumors and disease progression by analyzing blood plasma.

Full Story